Views & Analysis Six factors shaping healthcare in emerging markets The factors shaping the healthcare landscape in emerging markets.
Views & Analysis Regulatory timelines in the Asia-Pacific Snapshot of clinical trial application processes in the region.
Views & Analysis India improves processes for clinical trials New initiatives from the country's regulator aim to smooth the registration of trials and ensure prospective participants fully understand what will be involved through mandatory AV recording o
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.